GlassScriptPhysician profile
Marilyn N Bataille
NPI 1538596929
$7,099.05
in general payments reported to CMS, 2019-2025
47 companies · $1,364 in 2025
The $1,364 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,819 · 2022: $1,268 · 2023: $1,520 · 2024: $1,127 · 2025: $1,364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,011.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $891.19 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $767.52 | 2021-2025 | Gardasil 9, Pneumovax 23, Vaxneuvance |
| Novo Nordisk INC | $674.26 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $595.45 | 2021-2025 | Evenity, Repatha, Otezla |
| Lilly USA, LLC | $477.57 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $431.36 | 2021-2025 | |
| Abbvie INC. | $370.11 | 2021-2025 | |
| Astellas Pharma US INC | $321.23 | 2021-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $305.25 | 2021-2024 | Xarelto |
| Sumitomo Pharma America, INC. | $227.03 | 2024-2025 | Gemtesa |
| Exact Sciences Corporation | $222.43 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.85 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $152.07 | 2023-2025 | Rexulti, Nuedexta |
| Kowa Pharmaceuticals America, INC. | $119.45 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $115.20 | 2021-2025 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marilyn Bataille listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.